This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Ares Trading S.a., Peptimmune, Inc.. Active years: 2010-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2013
Title: Innovations by Inventor Keith Johnson
Introduction
Keith Johnson is an accomplished inventor based in Hudson, MA (US). He holds two patents that focus on novel methods for treating diseases using random copolymers. His work has significant implications for the treatment of autoimmune diseases, particularly multiple sclerosis.
Latest Patents
Johnson's latest patents involve methods of treating disease with random copolymers. These inventions relate to the administration of copolymers comprising amino acids such as tyrosine (Y), phenylalanine (F), alanine (A), and lysine (K). The patents detail treatment regimens that include formulations administered at intervals greater than 24 hours, as well as sustained release formulations. Additionally, the inventions encompass methods for conducting a pharmaceutical business, including the manufacturing, licensing, or distribution of related kits.
Career Highlights
Throughout his career, Johnson has worked with notable companies, including Peptimmune, Inc. and Ares Trading S.a. His experience in these organizations has contributed to his expertise in the field of pharmaceutical innovations.
Collaborations
Johnson has collaborated with several professionals in his field, including James Rasmussen and Jianxin Zhang. These partnerships have likely enhanced his research and development efforts.
Conclusion
Keith Johnson's contributions to the field of medical treatment through his innovative patents demonstrate his commitment to advancing healthcare solutions. His work continues to impact the treatment of autoimmune diseases and pharmaceutical practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile